Despite this, TNF blockade with etanercept, a soluble fusion protein containing the TNF-binding domain of TNFR2, did not significantly enhance the efficacy of gemcitabine as a single agent in patients with advanced pancreatic cancer.49 The gene discussed is TNFRSF1B; the disease is pancreatic neoplasm.